Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (326)	2/1/1999 8:12:00 AM
From: LLCF	Read Replies (1) \| Respond to of 613

< What I found intriguing about the article was the info on the fact that even though the body will "try" to reject an organ transplant, the brain will not reject the implanting of cells there. I wonder why the immune system is so particular about a new kidney but will allow this to happen. Any ideas?> Yea thats interesting, and I'll certainly defer to others with the "background" to answer properly, but will say from what I remember theres something about this protecting the brain from its own bodies defense system. ICOS will be interesting today, will watch... It also apprears that if these stocks continue to act like CORR and CEPH (after approvals) then why risk holding anything until drugs get approved and cash starts flowing? DAK

To: Arthur Radley who wrote (326)	2/1/1999 3:51:00 PM
From: Linda Pearson	Read Replies (4) \| Respond to of 613

TexasDude, <I don't know. SCIOS will probably take a hit today even though they got a rec. for their heart drug on Friday. Local TV carried news about this new drug, but it appears that from the review panel they were not impressed with the potential for the drug. Today's WSJ has article today and it isn't upbeat.> Gee, I didn't find any article on Scios in the Wall Street Journal, let alone one that isn't upbeat. Maybe you can provide the article for those of us who are curious why you are slamming the stock. Thanks, Linda